Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell


Temporarily Closed

Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined with MEDI4736 (Durvalumab) in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (ARCHON-1)


LU004 is temporarily closed to accrual effective immediately, April 13, 2020. The study has enrolled 6 patients to Cohort 2 (the standard radiation + MEDI4736 (durvalumab) arm) and will be temporarily closed while the safety of the protocol treatment regimen in both cohorts is monitored.